In the 2022/2023 business year, we spent EUR 48 million on research and development

Active Agent Production Renewed

By renewing our active agent base, we wish to simultaneously raise the rate of our active agents produced internally in a reliable quality and at a competitive price as well as to increase our exports.

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox